文献速递肺外科食管与纵隔外科

单孔机器人胸外科手术用于肺切除与胸腺切除的早期结果与技术

Early Results and Technique of Single-Port (SP) Robotic Thoracic Surgery for Pulmonary Resection and Thymectomy.
PubMed 文献 · Ann Thorac Surg · 2026-09-04

回顾性分析2024年9月至2026年1月共82例接受单孔机器人胸外科手术的患者,包括胸腺切除28例、肺叶切除32例、肺段切除17例、肺楔形切除5例。中位手术时间胸腺切除101分钟、肺切除137分钟,中位住院1天,无主要并发症及30/90天死亡,60天再入院率1%。结论认为单孔机器人系统联合新型机器人吻合器用于胸腺切除和复杂解剖性肺切除可行且安全。

要点

  • 单孔机器人胸外科手术用于胸腺切除和肺叶/肺段切除可行且安全。
  • 中位住院时间1天,无主要并发症及30/90天死亡。
  • 新型单孔机器人吻合器在最后38例中使用无故障。

核心结论

  • 单孔机器人胸外科手术联合新型单孔机器人吻合器用于胸腺切除和复杂解剖性肺切除(包括肺叶切除和肺段切除)可行且安全。

研究设计与样本

  • 回顾性分析2024年9月至2026年1月连续接受胸外单切口单孔机器人系统手术的患者,共82例(44例女性)。

主要发现

  • 手术类型为胸腺切除28例、肺叶切除32例、肺段切除17例、肺楔形切除5例。
  • 中位手术时间胸腺切除101分钟,肺切除137分钟。
  • 胸腺切除中位胸管留置时间0小时,54例肺切除患者为7.3小时。
  • 中位实际出血量20 mL(范围15-40),中位住院时间所有患者均为1天。
  • 中位淋巴结计数右侧29枚、左侧23枚(中位5个N2站和3个N1站),全部R0切除。

关键数值与推荐

  • 无患者发生主要并发症(Clavien-Dindo分级>IIIa)。
  • 无30天或90天死亡,60天内再入院率1%。
  • 新型单孔机器人吻合器在最后38例患者中使用,无故障。

临床怎么用

  • 对于适合胸腺切除或解剖性肺切除的患者,单孔机器人系统可作为可行的微创选择。
  • 术后胸管留置时间短、住院时间短,有利于加速康复。

局限性

  • 回顾性分析,非随机对照,样本量有限(82例)。
  • 单中心早期经验,随访时间短,结论需更大样本和长期随访验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The new single-port (SP) robotic system is increasingly being used for thoracic surgery. METHODS: A retrospective analysis of consecutive patients who underwent extrathoracic, single-incision surgery, using the SP robotic system between September 2024 and January 2026. RESULTS: From September 2024 to January 2026, 82 patients (44 women) underwent SP robotic thoracic surgery. The median height and body mass index were 165.1 cm (5'5″) and 26.6 kg/m2, respectively. Types of operations were thymectomy (n = 28), lobectomy (n = 32), segmentectomy (n = 17), and pulmonary wedge resection (n = 5). Median operative time was 101 minutes for thymectomy and 137 minutes for lung resection. Median chest tube duration for thymectomy was 0 hour and was 7.3 hours in the 54 patients who underwent pulmonary resection. Median actual blood loss was 20 mL (range 15-40). The median hospital length of stay was 1 day for all. The median lymph node count was 29 in the right chest and 23 in the left (median of 5 N2 and 3 N1 stations). All had R0 resections. The new SP robotic stapler, used in the last 38 patients, had no malfunctions. No patient experienced major complications (Clavien-Dindo grade > IIIa). There was no 30- or 90-day mortality, and the readmission rate within 60 days was 1%. CONCLUSIONS: This initial experience, the largest report outside of South Korea, shows that robotic thoracic surgery using the da Vinci SP robotic surgical system, with the new SP robotic stapler, is feasible and safe for thymectomy and complex anatomic lung resections, including lobectomy and segmentectomy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Pachos N, Cerfolio RJ, Bizekis C, et al. Early Results and Technique of Single-Port (SP) Robotic Thoracic Surgery for Pulmonary Resection and Thymectomy. Ann Thorac Surg. 2026. PMID: 42697395. doi:10.1016/j.athoracsur.2026.07.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。